MARATTO

article · ChemistrySelect

Computational Modeling and Assessment of Si@GRP as an Innovative Esomeprazole Drug Delivery System: A DFT Investigation

Abstract

ABSTRACT Esomeprazole (EPZ), a proton pump inhibitor (PPI), is widely used for acid‐related disorders but is associated with side effects, such as headaches, diarrhea, stomach pain, and neurological symptoms, raising concerns about its safety. This study employs density functional theory (DFT) at the PW6B95‐D3/LANL2DZ level to model a silicon‐doped graphene (Si@GRP) system co‐doped with sulfur (S), selenium (Se), and tellurium (Te) as a potential EPZ carrier. The HOMO–LUMO analysis indicates a moderate energy gap (Δ E = 2.23 eV), suggesting favorable reactivity, which aligns with nucleophilic sites observed in molecular electrostatic potential (MESP) plots. EPZ‐Si@GRP exhibits a moderate adsorption energy of ‐3.26 eV, indicating balanced adsorption and desorption characteristics. Stability is further supported by natural bond orbital (NBO) analysis, showing consistent E 2 values of 302.75, 296.6, 267.6, and 155.6 kcal/mol respectively. Quantum theory of atoms in molecules (QTAIM) analysis confirms robust bonding interactions, while non‐covalent interaction (NCI) plots highlight strong Van der Waals forces, reinforcing the non‐covalent nature of EPZ binding. These findings suggest that Si@GRP is a promising delivery material for EPZ, offering enhanced stability and controlled release potential.

Research topics

  • Boron and Carbon Nanomaterials Research
  • Graphene research and applications
  • Graphene and Nanomaterials Applications

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1002/slct.202501240

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.